All Stories

  1. The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria
  2. Family quality‐of‐life burden in chronic spontaneous urticaria: A multicentre study
  3. The OX40-OX40L Co-stimulatory pathway in dermatology: emerging frontiers for therapeutic approaches
  4. The Prevalence of Symptomatic Dermographism: Results of the International UCARE PREVALENCE‐D Study
  5. Chronic spontaneous urticaria: update on pathogenesis and therapeutic implications
  6. Urticária crônica espontânea: atualização na patogênese e implicações terapêuticas
  7. Dermatose terra firma‐forme exuberante em paciente idoso
  8. Exuberant terra firma-forme dermatosis in an elderly patient⋆
  9. Chronic pruritus: a narrative review
  10. Prurido crônico: revisão narrativa
  11. IgE as a predictor to omalizumab response in patients with chronic spontaneous urticaria
  12. DRESS syndrome: an interaction between drugs, latent viruses, and the immune system
  13. Update on the pathogenesis of atopic dermatitis
  14. Treatment with risankizumab for nivolumab‐induced psoriasis in a patient with metastatic clear cell renal carcinoma
  15. Prurigo: review of its pathogenesis, diagnosis, and treatment
  16. Bibliometric evaluation of Anais Brasileiros de Dermatologia (2013-2022)
  17. Urticarial Vasculitis Differs From Chronic Spontaneous Urticaria in Time to Diagnosis, Clinical Presentation, and Need for Anti-Inflammatory Treatment: An International Prospective UCARE Study
  18. Association of non-fatal symmetrical peripheral gangrene and COVID-19
  19. Chronic Urticaria and Angioedema: Masqueraders and Misdiagnoses
  20. How Infection and Vaccination Are Linked to Acute and Chronic Urticaria: A Special Focus on COVID-19
  21. New small molecules in dermatology: for the autoimmunity, inflammation and beyond
  22. JAK-STAT pathway inhibitors in dermatology
  23. Prevalence of filaggrin gene polymorphisms (exon-3) in patients with atopic dermatitis in a multiracial Brazilian population
  24. Eosinophilia and elevated IgE serum levels: a red flag: when your diagnosis is not a common atopic eczema or common allergy
  25. Livedoid Vasculopathy: Clinical, Histopathological, and Therapy Evaluation
  26. Primary Cutaneous Cryptococcosis Caused by Cryptococcus gatti in an Elderly Patient
  27. Pityriasis rubra pilaris (type I) following ChAdOx1 COVID‐19 vaccine: A report of two cases with successful treatment with oral isotretinoin
  28. Vasculitis in the setting of COVID ‐19: from the disease to the vaccine. Report of a case of cutaneous vasculitis after immunization
  29. Post‐COVID‐19 hair loss: prevalence and associated factors among 5,891 patients
  30. Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial
  31. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
  32. M2 macrophage polarization in chronic spontaneous urticaria refractory to antihistamine treatment
  33. Allergic contact dermatitis by ophthalmological medications in Brazil: experience of a dermatology department
  34. COVID‐19 and skin diseases: results from a survey of 843 patients with atopic dermatitis, psoriasis, vitiligo and chronic urticaria
  35. Chromoblastomycosis evolving to sarcomatoid squamous cell carcinoma: A case report
  36. Adverse events of the yellow fever vaccine in chronic urticaria: evaluation of patients treated or not with omalizumab compared to healthy individuals
  37. What lessons can we learn? Clinical and epidemiological retrospective analysis of 267 patients with urticaria in a Brazilian tertiary center
  38. Urticarial vasculitis revealing immunolabelled nucleocapsid protein of SARS‐CoV‐2 in two Brazilian asymptomatic patients: the tip of the COVID‐19 hidden iceberg?
  39. International registry of dermatological manifestations secondary to COVID‐19 infection in 347 Hispanic patients from 25 countries
  40. A case of tuberculosis verrucosa cutis in Brazil undiagnosed for 15 years
  41. First report of cutaneous mycetoma by Paecilomyces variotii and the successful treatment with combined itraconazole and terbinafine along with resection surgeries
  42. A late diagnosis of hyperhomocysteinemia with probable evolution to verrucous elephantiasis nostra and leg ulcers
  43. Axillary papules: an uncommon location of lichen nitidus
  44. Evaluation of serum levels of C-reactive protein, D-Dimer and Autologous Serum Skin Test in patients with Chronic Spontaneous Urticaria in a Brazilian tertiary center : a cross-sectional study
  45. Socioeconomic impact of high-cost drugs in Brazilian dermatology. Legal and financial aspects, and impact on clinical practice
  46. Livedoid vasculopathy in 75 Brazilian patients in a single‐center institution: Clinical, histopathological and therapy evaluation
  47. The global impact of the COVID‐19 pandemic on the management and course of chronic urticaria
  48. Sarcoidosis with necrobiosis‐lipoidica–like skin lesions: A challenge for the dermatologist
  49. Granuloma Annulare: a Review of the Literature
  50. From dermatological conditions to COVID ‐19: Reasoning for anticoagulation, suppression of inflammation, and hyperbaric oxygen therapy
  51. Case Report: An Uncommon Clinical Case of Fatal Adult T-Cell Leukemia/Lymphoma Associated with HTLV-1 and Suspected due to Cutaneous Lesions and Epidemiologic Data
  52. Case Report: Treatment of Chromoblastomycosis with Combinations including Acitretin: A Report of Two Cases
  53. Potential interactions of SARS‐CoV‐2 with human cell receptors in the skin: Understanding the enigma for a lower frequency of skin lesions compared to other tissues
  54. Less is more: study on the different ways of closing surgical wounds after Mohs micrographic surgery
  55. Termo de consentimento informado: impacto na decisão judicial
  56. Chronic spontaneous urticaria exacerbation in a patient with COVID‐19: rapid and excellent response to omalizumab
  57. What the physicians should know about mast cells, dendritic cells, urticaria, and omalizumab during COVID ‐19 or asymptomatic infections due to SARS‐CoV ‐2?
  58. Lessons from dermatology about inflammatory responses in Covid‐19
  59. Unilateral verrucous plaque in a 14‐year‐old child
  60. Dupilumab as a useful treatment option for prurigo nodularis in an elderly patient with atopic diathesis
  61. Grammatically uniform population initialization for grammar-guided genetic programming
  62. Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
  63. Pernio during the COVID-19 pandemic and review of inflammation patterns and mechanisms of hypercoagulability
  64. Panniculitis as main clinical manifestation of alpha‐1 antitrypsin deficiency revealing a SerpinA1 gene mutation
  65. Botryomycosis in Patient With Pituitary Microadenome: A Case Report
  66. Multinucleate cell angiohistiocytoma: an uncommon cutaneous tumor in private practice
  67. Update on vasculitis: overview and relevant dermatological aspects for the clinical and histopathological diagnosis – Part II
  68. Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence
  69. Clinical variability of the GJB4: c.35G > A gene variant : a study of a large Brazilian erythrokeratodermia pedigree
  70. Update on vasculitis: an overview and dermatological clues for clinical and histopathological diagnosis – part I
  71. A Rare Case of Multiple Variants of Porokeratosis in the Same Patient: The Clue of Dermoscopy for Diagnosis and Therapeutical Update
  72. Livedo Racemosa: Clinical, Laboratory, and Histopathological Findings in 33 Patients
  73. Successful treatment of chromoblastomycosis caused by Fonsecaea pedrosoi using imiquimod
  74. Diagnóstico e terapêutica precoce de vasculite leucocitoclástica: relato de caso
  75. Atypical clinical presentation of an Arthroderma gypseum infection in a renal transplant recipient
  76. Correlation Between Demographic and Tumor Characteristics in Non-melanoma Skin Cancers Submitted to Mohs Micrographic Surgery
  77. Trichophyton rubrum Elicits Phagocytic and Pro-inflammatory Responses in Human Monocytes Through Toll-Like Receptor 2
  78. Is macular lymphocytic arteritis limited to the skin? Long-term follow-up of seven patients
  79. Characterization of subtypes of Blastocystis sp. isolated from patients with urticaria, São Paulo, Brazil
  80. Ungual warts: comparison of treatment with intralesional bleomycin and electroporation in terms of efficacy and safety
  81. Panniculitides of particular interest to the rheumatologist
  82. Consensus on the diagnostic and therapeutic management of chronic spontaneous urticaria in adults - Brazilian Society of Dermatology
  83. Association between frontal fibrosing alopecia and linear scleroderma “coup de sabre”
  84. What lessons can we learn from an apparent decrease in the use of topical drugs for psoriasis?
  85. In situ immune response in human dermatophytosis: possible role of Langerhans cells (CD1a+) as a risk factor for dermatophyte infection
  86. Radiotherapy-induced Pemphigus Foliaceous: a rare adverse effect of breast cancer therapy
  87. The train tracks sign is a valuable skin marker of envenomations caused by caterpillars
  88. Immunological Pathways in Hidradenitis Suppurativa: Current Concepts and Innovative Therapies
  89. The management of livedoid vasculopathy focused on direct oral anticoagulants (DOACs): four case reports successfully treated with rivaroxaban
  90. Comparison of diagnostic methods to detect Histoplasma capsulatum in serum and blood samples from AIDS patients
  91. Histopathological and clinical evaluation of chronic spontaneous urticaria patients with neutrophilic and non-neutrophilic cutaneous infiltrate
  92. Livedoid vasculopathy: a compelling diagnosis
  93. Skin cancer prevention campaign in childhood: survey based on 3676 children in Brazil
  94. Recurrent and disseminated pityriasis versicolor: A novel clinical form consequent to Malassezia -host interaction?
  95. Analysis of serum levels and cutaneous expression of Lipoprotein (a) in 38 patients with livedoid vasculopathy
  96. Longitudinal melanonychia due to voriconazole therapy during treatment of chromoblastomycosis
  97. Investigation of superficial mycosis in cutaneous allergy patients using topical or systemic corticosteroids
  98. Urticaria multiforme: Two cases with histopathological findings
  99. Hemodialysis and Kidney Transplantation as Predisposing Conditions to Onychomycosis
  100. Polymorphisms on IFNG , IL12B and IL12RB1 genes and paracoccidioidomycosis in the Brazilian population
  101. Clinicopathologic correlation of 282 leukocytoclastic vasculitis cases in a tertiary hospital: a focus on direct immunofluorescence findings at the blood vessel wall
  102. Epidemiological, clinical and laboratory profiles of cutaneous polyarteritis nodosa patients: Report of 22 cases and literature review
  103. Clinicopathologic correlation of 282 leukocytoclastic vasculitis cases in a tertiary hospital
  104. Use of Smartphones in Telemedicine: Comparative Study Between Standard and Teledermatological Evaluation of High-Complex Care Hospital Inpatients
  105. Thrombophilia: the dermatological clinical spectrum
  106. Lipoprotein(a) and livedoid vasculopathy: A new thrombophilic factor?
  107. Amantadine-Induced Livedo Racemosa
  108. Lipoprotein(a) and livedoid vasculopathy: A new thrombophilic factor?
  109. Chronic widespread dermatophytosis due to Trichophyton rubrum: a syndrome associated with a Trichophyton-specific functional defect of phagocytes
  110. Nail Sarcoidosis with and without Systemic Involvement: Report of Two Cases
  111. Livedoid vasculopathy and high levels of lipoprotein (a): response to danazol
  112. Chronic urticaria in adults: state-of-the-art in the new millennium
  113. TOLL-LIKE RECEPTORS (TLR) 2 AND 4 EXPRESSION OF KERATINOCYTES FROM PATIENTS WITH LOCALIZED AND DISSEMINATED DERMATOPHYTOSIS
  114. Monocyte-Derived Dendritic Cells from Patients with Dermatophytosis Restrict the Growth of Trichophyton rubrum and Induce CD4-T Cell Activation
  115. Atrophie Blanche
  116. Quality-of-life impairment in patients with livedoid vasculopathy
  117. Propylthiouracil-Induced Vasculitis With Antineutrophil Cytoplasmic Antibody
  118. In Situ Immune Response in Human Chromoblastomycosis – A Possible Role for Regulatory and Th17 T Cells
  119. Cutaneous New World Leishmaniasis on a Port-wine stain birthmark
  120. Elevated Levels of Coagulation Factor VIII in Patients With Venous Leg Ulcers
  121. Plasmacytoid dendritic cells in cutaneous lesions of patients with chromoblastomycosis, lacaziosis, and paracoccidioidomycosis: a comparative analysis
  122. Topical Application of Imiquimod as a Treatment for Chromoblastomycosis
  123. Livedoid vasculopathy: An in-depth analysis using a modified Delphi approach
  124. Dermoscopy examination of petechial lesions in a patient with Dermatitis Herpetiformis
  125. Unilateral Livedoid Vasculopathy Associated With Involutional Phase of Cutaneous Infantile Hemangioma
  126. Tungiasis under dermoscopy: in vivo and ex vivo examination of the cutaneous infestation due to Tunga penetrans
  127. Cutaneous Manifestations and Comorbidities in 60 Cases of Takayasu Arteritis
  128. Evaluation of D-dimer serum levels among patients with chronic urticaria, psoriasis and urticarial vasculitis
  129. Direct immunofluorescence findings and thrombophilic factors in livedoid vasculopathy: how do they correlate?
  130. Cutaneous Manifestations and Comorbidities in 60 Cases of Takayasu Arteritis
  131. Dermoscopy revealing a case of Tinea Nigra*
  132. The use of nested Polymerase Chain Reaction (nested PCR) for the early diagnosis of Histoplasma capsulatum infection in serum and whole blood of HIV-positive patients*
  133. Autoimmunity Diseases of the Skin
  134. Topical photoprotection in childhood and adolescence
  135. Drug reaction with Eosinophilia and Systemic Symptoms (DRESS) / Drug-induced Hypersensitivity Syndrome (DIHS): a review of current concepts
  136. Immunoelectron microscopy study of superficial skin nerves in drug-induced acute urticaria
  137. Dermal dendrocytes FXIIIA+ phagocytizing extruded mast cell granules in drug-induced acute urticaria
  138. Back to our past...
  139. Association between multiple skin tags and insulin resistance
  140. Association of acanthosis nigricans and skin tags with insulin resistance
  141. Analysis of the Expression of Toll-like Receptors 2 and 4 in Keratinocytes of Patients with Extensive Dermatophytosis due Trichophyton rubrum
  142. Candida parapsilosiscandidaemia in a neonatal unit over 7 years: a case series study
  143. Vasculopatia livedoide: uma doença cutânea intrigante
  144. Micoses superficiais e os elementos da resposta imune
  145. Balanite plasmocitária de Zoon: relato de dois casos tratados com pimecrolimo
  146. Urticaria and dermographism in patients with adult-onset Still’s disease
  147. Aos Editores dos Anais Brasileiros de Dermatologia (Brazilian Annals of Dermatology)
  148. Livedoid vasculopathy secondary to high levels of lipoprotein(a)
  149. Entodermoscopia: dermatoscopia de epiluminescência para diagnose da pediculose
  150. Livedoid vasculopathy as a coagulation disorder
  151. Cimidíase (dermatose por percevejo): uma causa de prurigo a ser lembrada
  152. Bedbugs (Cimicidae infestation): the worldwide renaissance of an old partner of human kind
  153. E-learning program for medical students in dermatology
  154. Blefarite e tricomegalia induzidas pelo cetuximabe
  155. Avaliação clínica, dermatoscópica e histopatológica do nevo de Meyerson: relato de caso
  156. Reações tegumentares adversas relacionadas aos agentes antineoplásicos: parte II
  157. Reações tegumentares adversas relacionadas aos agentes antineoplásicos: parte I
  158. Cromoblastomicose: relato de 27 casos e revisão da literatura
  159. Tratamento do papiloma vírus humano na infância com creme de imiquimode a 5%
  160. Extensive long-standing chromomycosis due toFonsecaea pedrosoi: Three cases with relevant improvement under voriconazole therapy
  161. Ixodíase revelada pela microscopia de epiluminescência sem contato com a pele
  162. Histamina, receptores de histamina e anti-histamínicos: novos conceitos
  163. Frequency of thrombophilia determinant factors in patients with livedoid vasculopathy and treatment with anticoagulant drugs - a prospective study
  164. Dermatite verrucosa de Pedroso e Gomes (Cromomicose): 90 anos depois, ainda entre nós
  165. Teledermatologia: correlação diagnóstica em serviço primário de saúde
  166. Multiple pustules on trunk, face, oral mucosa, genital area, palms and soles, arthalgia and anterior chest wall osteitis
  167. A comparative study of single-dose treatment of chancroid using thiamphenicol versus Azithromycin
  168. Monocyte-derived dendritic cells from patients with severe forms of chromoblastomycosis induce CD4+T cell activationin vitro
  169. Doações
  170. Vasculites dos médios e grandes vasos
  171. Prevalence of thrombophilia associated with leg ulcers
  172. S.138. Waldenstrom Hyperglobulinemic Purpura in a Patient with Chronic Mucocutaneous Candidiasis
  173. Manifestações cutâneas das trombofilias
  174. Fusariose em paciente imunocomprometido: sucesso terapêutico com voriconazol
  175. Influence of the human activity in the Atlantic Forest and in the prevalence of etiological agents of dermatophytosis in a coastal city of Southern Brazil Ubatuba (So Paulo)
  176. Urticaria unresponsive to antihistaminic treatment: An open study of therapeutic options based on histopathologic features
  177. Blisters on the legs
  178. Leg ulcers associated with factor V Leiden and prothrombin G20210A and methyltetrahydrofolate reductase mutations: successful treatment with warfarin
  179. Thalidomide inhibits human ultraviolet-B-induced skin inflammation?
  180. An unusual association between scalp psoriasis and ophiasic alopecia areata: the Renbök phenomenon
  181. Childhood-onset skin necrosis resulting from protein C deficiency
  182. The inflammatory response in drug-induced acute urticaria: ultrastructural study of the dermal microvascular unit
  183. Cellular immune response of patients with chromoblastomycosis undergoing antifungal therapy
  184. Urticaria as a Cutaneous Sign of Adult-Onset Still's Disease
  185. Atrophia maculosa varioliformis cutis: a case with extrafacial involvement and familial facial lesions
  186. Tinea Faciei in an Infant Caused by Microsporum gypseum Simulating a Dry Impetigo
  187. Extensive nodular cutaneous amyloidosis: an unusual presentation
  188. Drug-Induced Hypersensitivity Syndrome Due to Anticonvulsants in a Two-Year-Old Boy
  189. Reações cutâneas graves adversas a drogas: aspectos relevantes ao diagnóstico e ao tratamento - Parte II
  190. Two case reports of cutaneous adverse reactions following hepatitis B vaccine: lichen planus and granuloma annulare
  191. Tinea Nigra: Report of Two Cases in Infants
  192. Acute generalized exanthematous pustulosis induced by ingestion of bamifylline
  193. Lichen sclerosus - a keratotic variant
  194. Necrobiotic xanthogranuloma with lambda paraproteinemia: case report of successful treatment with melphalan and prednisone
  195. Keratosis lichenoides chronica: Report of a case developing after erythroderma
  196. Invasive hyalohyphomycosis due to Fusarium solani in a patient with acute lymphocytic leukemia
  197. 10.1016/j.abdp.2024.10.017
  198. 10.1016/j.abdp.2024.08.001
  199. 10.1016/j.abdp.2024.03.001
  200. 10.1016/j.abdp.2023.10.001
  201. 10.1016/j.abdp.2023.05.018
  202. 10.1016/j.abdp.2020.09.027
  203. 10.1016/j.abdp.2020.12.003
  204. 10.1016/j.abdp.2020.04.012
  205. 10.1016/j.abdp.2020.07.014
  206. 10.1016/j.abdp.2020.04.011
  207. 10.1016/j.abdp.2020.08.009
  208. 10.1016/j.abdp.2020.05.019
  209. 10.1016/j.abdp.2020.05.005
  210. 10.1016/j.abdp.2020.04.003
  211. 10.1016/j.abdp.2020.01.004
  212. 10.1016/j.abdp.2019.05.001
  213. Urticária e doenças sistêmicas
  214. Melanoma maligno cutâneo primário: estudo retrospectivo de 1963 a 1997 no Hospital do Servidor Público Estadual de São Paulo
  215. DEEP FUNGAL INFECTIONS